252 related articles for article (PubMed ID: 15896776)
1. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
Cook AL; Smith AG; Smit DJ; Leonard JH; Sturm RA
Exp Cell Res; 2005 Aug; 308(1):222-35. PubMed ID: 15896776
[TBL] [Abstract][Full Text] [Related]
2. SOX10, in combination with Sp1, regulates the endothelin receptor type B gene in human melanocyte lineage cells.
Yokoyama S; Takeda K; Shibahara S
FEBS J; 2006 Apr; 273(8):1805-20. PubMed ID: 16623715
[TBL] [Abstract][Full Text] [Related]
3. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
[TBL] [Abstract][Full Text] [Related]
4. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
Cook AL; Sturm RA
Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
[TBL] [Abstract][Full Text] [Related]
5. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
6. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression.
Finzsch M; Stolt CC; Lommes P; Wegner M
Development; 2008 Feb; 135(4):637-46. PubMed ID: 18184726
[TBL] [Abstract][Full Text] [Related]
7. Functional difference of the SOX10 mutant proteins responsible for the phenotypic variability in auditory-pigmentary disorders.
Yokoyama S; Takeda K; Shibahara S
J Biochem; 2006 Oct; 140(4):491-9. PubMed ID: 16921166
[TBL] [Abstract][Full Text] [Related]
8. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
9. Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3.
Cook AL; Donatien PD; Smith AG; Murphy M; Jones MK; Herlyn M; Bennett DC; Leonard JH; Sturm RA
J Invest Dermatol; 2003 Nov; 121(5):1150-9. PubMed ID: 14708619
[TBL] [Abstract][Full Text] [Related]
10. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
[TBL] [Abstract][Full Text] [Related]
11. Neural crest development is regulated by the transcription factor Sox9.
Cheung M; Briscoe J
Development; 2003 Dec; 130(23):5681-93. PubMed ID: 14522876
[TBL] [Abstract][Full Text] [Related]
12. The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia.
Mollaaghababa R; Pavan WJ
Oncogene; 2003 May; 22(20):3024-34. PubMed ID: 12789277
[TBL] [Abstract][Full Text] [Related]
13. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
14. Sox10 overexpression induces neural crest-like cells from all dorsoventral levels of the neural tube but inhibits differentiation.
McKeown SJ; Lee VM; Bronner-Fraser M; Newgreen DF; Farlie PG
Dev Dyn; 2005 Jun; 233(2):430-44. PubMed ID: 15768395
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
16. Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence.
Kellerer S; Schreiner S; Stolt CC; Scholz S; Bösl MR; Wegner M
Development; 2006 Aug; 133(15):2875-86. PubMed ID: 16790476
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2-associated athanogene-1 (BAG-1): a transcriptional regulator mediating chondrocyte survival and differentiation during endochondral ossification.
Tare RS; Townsend PA; Packham GK; Inglis S; Oreffo RO
Bone; 2008 Jan; 42(1):113-28. PubMed ID: 17950682
[TBL] [Abstract][Full Text] [Related]
18. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
19. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
20. Mitf expression is sufficient to direct differentiation of medaka blastula derived stem cells to melanocytes.
Béjar J; Hong Y; Schartl M
Development; 2003 Dec; 130(26):6545-53. PubMed ID: 14660543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
